Making New Connections in NJ
Earlier this month, members of the LRG staff were invited to the Rutgers Cancer Institute of New Jersey by sarcoma specialist Dr. Roman Groisberg.
Institute of Medicine Report Findings on Diagnostic Error
A recent report from the Institute of Medicine (IOM), Improving Diagnosis in Healthcare, outlines findings on the state of diagnostic error in our healthcare system. A follow-up to the 2000 landmark study, To Err [...]
Epidemiology of GIST
Dr. Jason Sicklick An interview with Dr. Jason Sicklick In a recently published study, Jason Sicklick, MD, surgical oncologist at University of California, San Diego Health System, and his team of researchers [...]
Understanding How GISTs Develop Enables Discovery of New Therapies
By Drs. Sebastian Bauer, West German Cancer Center, University of Essen, Germany and Jonathan Fletcher, Brigham & Women’s Hospital, Harvard University, LRG Research Team Researchers talk plainly about microGISTs, how this cancer develops and what all [...]
PDGFRA Mutations: It’s time to consider mutational status for resistant GIST patients
January 6th, 2011 - By Jerry Call, LRG Science CoordinatorThe first ever clinical trial specifically for the PDGFRA D842V mutation has been announced by Arog pharmaceuticals. The phase II trial is scheduled to open in [...]
New Treatments of D842V Mutations
UPDATE - January 6th, 2011 by Jerry Call, LRG Science Coordinator The first ever clinical trial specifically for the PDGFRA D842V mutation has been announced by Arog pharmaceuticals. The phase II trial is scheduled [...]
GIST diagnosis: the pathologist’s perspective
Dr. Chris CorlessKnight Cancer InstitutePortland, Oregon For a patient suddenly faced with a cancer diagnosis, the process by which the diagnosis was made may seem of little interest. It is only the [...]